List of Excipients in API MITOTANE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing MITOTANE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| ER Squibb & Sons LLC | LYSODREN | mitotane | 0015-3080 | CELLULOSE, MICROCRYSTALLINE | |
| ER Squibb & Sons LLC | LYSODREN | mitotane | 0015-3080 | POLYETHYLENE GLYCOL 3350 | |
| ER Squibb & Sons LLC | LYSODREN | mitotane | 0015-3080 | SILICON DIOXIDE | |
| ESTEVE PHARMACEUTICALS SA | LYSODREN | mitotane | 68118-080 | CELLULOSE, MICROCRYSTALLINE | |
| ESTEVE PHARMACEUTICALS SA | LYSODREN | mitotane | 68118-080 | POLYETHYLENE GLYCOL 3350 | |
| ESTEVE PHARMACEUTICALS SA | LYSODREN | mitotane | 68118-080 | SILICON DIOXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for MITOTANE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
MITOTANE drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | mitotane | 0015-3080 |
| ESTEVE PHARMACEUTICALS SA | mitotane | 68118-080 |
| HRA Pharma Rare Diseases | mitotane | 76336-080 |
| >Company | >Ingredient | >NDC |
MITOTANE drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
MITOTANE drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | mitotane | 0015-3080 |
| ESTEVE PHARMACEUTICALS SA | mitotane | 68118-080 |
| HRA Pharma Rare Diseases | mitotane | 76336-080 |
| >Company | >Ingredient | >NDC |
MITOTANE drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
MITOTANE drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | mitotane | 0015-3080 |
| ESTEVE PHARMACEUTICALS SA | mitotane | 68118-080 |
| HRA Pharma Rare Diseases | mitotane | 76336-080 |
| >Company | >Ingredient | >NDC |
MITOTANE drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
MITOTANE drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| ESTEVE PHARMACEUTICALS SA | mitotane | 68118-080 |
| HRA Pharma Rare Diseases | mitotane | 76336-080 |
| >Company | >Ingredient | >NDC |
MITOTANE drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | mitotane | 0015-3080 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
